TuHURA Biosciences, Inc.
HURA
$3.64
$0.267.69%
12/31/2024 | 09/30/2024 | 12/31/2023 | |||
---|---|---|---|---|---|
Revenue | -- | -- | -- | ||
Total Other Revenue | -- | -- | -- | ||
Total Revenue | -- | -- | -- | ||
Cost of Revenue | -- | -- | -- | ||
Gross Profit | -- | -- | -- | ||
SG&A Expenses | 1.72M | 783.50K | 752.10K | ||
Depreciation & Amortization | -- | -- | -- | ||
Other Operating Expenses | -- | -- | -- | ||
Total Operating Expenses | 5.69M | 3.73M | 2.66M | ||
Operating Income | -5.69M | -3.73M | -2.66M | ||
Income Before Tax | -6.00M | -5.58M | -2.68M | ||
Income Tax Expenses | -- | -- | -- | ||
Earnings from Continuing Operations | -6.00M | -5.58M | -2.68M | ||
Earnings from Discontinued Operations | -- | -- | -- | ||
Extraordinary Item & Accounting Change | -- | -- | -- | ||
Minority Interest in Earnings | -- | -- | -- | ||
Net Income | -6.00M | -5.58M | -2.68M | ||
EBIT | -5.69M | -3.73M | -2.66M | ||
EBITDA | -5.68M | -3.70M | -2.62M | ||
EPS Basic | -0.14 | -0.09 | -0.04 | ||
Normalized Basic EPS | -0.09 | -0.05 | -0.02 | ||
EPS Diluted | -0.14 | -0.09 | -0.04 | ||
Normalized Diluted EPS | -0.09 | -0.05 | -0.02 | ||
Average Basic Shares Outstanding | 42.32M | 76.37M | 68.01M | ||
Average Diluted Shares Outstanding | 42.32M | 76.37M | 68.01M | ||
Dividend Per Share | -- | -- | -- | ||
Payout Ratio | -- | -- | -- |